The content on this site is intended for healthcare professionals only
Lateral pelvic lymphadenectomy (LPLD) is routinely performed in advanced lower rectal cancers in Eastern countries, whereas in the western world it has not progressed to a frequently performed technique because of the adoption of Total Mesorectal Excision that contributed to decrease local relapses. LPLD consists of a complete dissection of the endopelvic fascia together with the rectum and mesorectum. This video presentation shows a bilateral pelvic lymph node dissection in a low rectal cancer.
New classification for identifying HR myeloma based on cytogenetic abnormalities
Daratumumab, bortezomib/thalidomide/dexamethasone (D-VTd) and DARA maintenance shows benefit in transplant-eligible NDMM
Isatuximab plus lenalidomide and dexamethasone with bortezomib as a new standard of care for NDMM TI non-frail patients
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Use of bispecifics and CAR T cells in South America
Revolutionising myeloma treatment through immune profiling
Treating relapsed multiple myeloma outside of use of T-cell redirected therapies
Guiding transplant decisions in multiple myeloma with MRD
Revolutionising multiple myeloma treatment with CAR T-Cell therapies
